Tag: FDA-approved pancreatic drugs 2024

Home / FDA-approved pancreatic drugs 2024

Categories

Irinotecan liposome is approved by the USFDA for first-line treatment of metastatic pancreatic adenocarcinoma

The Food and Drug Administration approved irinotecan liposome (Onivyde, Ipsen Biopharmaceuticals, Inc.) with oxaliplatin, fluorouracil, and leucovorin on February 13, 2024, for treating metastatic pa...
fda-approved-pancreatic-drugs-2024

Scan the code